Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells-Reference-Cited by-同舟云学术

Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells

Published:2016-11-28 Issue:1 Volume:18 Page:74-85
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Heink Sylvia,Yogev Nir,Garbers Christoph^ORCID,Herwerth Marina,Aly Lilian^ORCID,Gasperi Christiane,Husterer Veronika,Croxford Andrew L,Möller-Hackbarth Katja,Bartsch Harald S,Sotlar Karl,Krebs Stefan,Regen Tommy,Blum Helmut,Hemmer Bernhard,Misgeld Thomas,Wunderlich Thomas F,Hidalgo Juan,Oukka Mohamed,Rose-John Stefan,Schmidt-Supprian Marc,Waisman Ari^ORCID,Korn Thomas

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3632.pdf

Reference47 articles.

1. Hall, A.O. et al. The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37, 511–523 (2012).

2. Neufert, C. et al. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur. J. Immunol. 37, 1809–1816 (2007).

3. Huber, M. et al. IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 20, 223–234 (2008).

4. Dardalhon, V. et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+IL-10+Foxp3− effector T cells. Nat. Immunol. 9, 1347–1355 (2008).

5. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells;Journal of Autoimmunity;2024-12

2. Targeting cytokine networks in neuroinflammatory diseases;Nature Reviews Drug Discovery;2024-09-11

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. The role of interleukin‐6 family cytokines in cancer cachexia;The FEBS Journal;2024-07-08

5. Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective;Hypertension;2024-07